Differenzielle Expression proatherogener Zellmarker auf Monozytensubpopulationen bei Patienten mit stabiler koronarer Herzkrankheit
Differential expression of proatherogenic cell markers on monocyte subpopulations of patients with stable coronary artery disease
by Hendrik Kuschicke
Date of Examination:2017-03-30
Date of issue:2017-03-29
Advisor:PD Dr. Frauke Stefanie Czepluch
Referee:PD Dr. Frauke Stefanie Czepluch
Referee:Prof. Dr. Martin Oppermann
Referee:Prof. Dr. Thomas Meyer
Files in this item
Name:Dissertation_170321_Endfassung_ediss_II.pdf
Size:2.34Mb
Format:PDF
Abstract
English
Monocytes and platelets are important cellular mediators of atherosclerosis. Human monocytes can be divided into CD14++CD16− , CD14++CD16+ and CD14+CD16++ cells, which differ in their functional properties. The aim of this thesis was to examine monocyte subset distribution, monocyte-platelet aggregate (MPA) formation, expression of CCR5, the receptor of the platelet-derived chemokine CCL5, of OPN receptor CD44, monocyte migration chemokine, of KLF4, an atheroprotective protein, and other soluble chemokines, to determine whether these parameters are altered in individuals with coronary atherosclerosis.
Keywords: coronary artery disease; monocyte subsets; monocyte subpopulations; MPA; OPN; CCR5; CCL5; RANTES